KI-Beratung Beta
Vor Ort
Merkzettel Warenkorb
  • Produktbild: Mucosal Delivery of Biopharmaceuticals
  • Produktbild: Mucosal Delivery of Biopharmaceuticals
  • Produktbild: Mucosal Delivery of Biopharmaceuticals
- 12%

Mucosal Delivery of Biopharmaceuticals Biology, Challenges and Strategies

12% sparen

139,99 € UVP 160,49 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

04.02.2014

Abbildungen

XIX, 601 p. 134 illus., 23 illus. in color.

Herausgeber

José das Neves + weitere

Verlag

Springer Us

Seitenzahl

601

Maße (L/B/H)

24,1/16/3,9 cm

Gewicht

1092 g

Auflage

2014

Sprache

Englisch

ISBN

978-1-4614-9523-9

Beschreibung

Portrait

José das Neves is a researcher at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, and in the Faculty of Pharmacy, University of Porto, Portugal, where he earned a Ph.D. in Pharmaceutical Sciences. His previous work has spanned multiple aspects of the development of vaginal drug delivery systems, and his current research interests include the development of nanotechnology-based solutions for the development of anti-HIV microbicides and mucosal delivery of biopharmaceuticals.Bruno Sarmento is an affiliated researcher at INEB – Instituto de Engenharia Biomédica, University of Porto, Portugal. He is also an assistant professor of pharmaceutical and biopharmaceutical technology at Instituto Superior de Ciências da Saúde-Norte, CESPU, Gandra, Portugal. He earned a Ph.D. in Pharmaceutical Technology at the University of Porto. He has extensive work in the development of nanocarriers for the oral delivery of biopharmaceuticals—namely insulin—and the establishment of novel in vitro intestinal permeability models. His current research focuses on nanomedicines and their applications in the pharmaceutical and biomedical fields.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

04.02.2014

Abbildungen

XIX, 601 p. 134 illus., 23 illus. in color.

Herausgeber

Verlag

Springer Us

Seitenzahl

601

Maße (L/B/H)

24,1/16/3,9 cm

Gewicht

1092 g

Auflage

2014

Sprache

Englisch

ISBN

978-1-4614-9523-9

Herstelleradresse

Springer-Verlag GmbH
Europaplatz 3
69115 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Mucosal Delivery of Biopharmaceuticals
  • Produktbild: Mucosal Delivery of Biopharmaceuticals
  • Produktbild: Mucosal Delivery of Biopharmaceuticals

  • Concepts in Mucosal Immunity and Mucosal Vaccines.- Mucoadhesion and Characterization of Mucoadhesive Properties.- Mucus as a Barrier for Biopharmaceuticals and Drug Delivery Systems.- Epithelial Permeation and Absorption Mechanisms of Biopharmaceuticals.- Oral Delivery of Biopharmaceuticals.- Buccal Delivery of Biopharmaceuticals: Vaccines and Allergens.- Pulmonary Delivery of Biopharmaceuticals.- Nasal Delivery of Biopharmaceuticals.- Ocular Delivery of Biopharmaceuticals.- Vaginal Delivery of Biopharmaceuticals.- Nanoparticles-in-Microsphere Oral Delivery Systems (NiMOS) for Nucleic Acid Therapy in the Gastrointestinal Tract.- Bacteria-Based Vectors for Oral Gene Therapy.- Self-Assembled Polysaccharide Nanogels for Nasal Delivery of Biopharmaceuticals.- Pheroid™ Vesicles and Microsponges for Nasal Delivery of Biopharmaceuticals.- Delivery Strategies for Developing siRNA-Based Vaginal Microbicides.- Delivery Strategies for Developing Vaginal DNA Vaccine Combining Cell-Penetrating Peptides and Jet Injection.- Vaccine Delivery Systems for Veterinary Immunization.- Eligen® Technology for Oral Delivery of Proteins and Peptides.- The RapidMist™ System for Buccal Delivery of Insulin.- The Pharmaceutical Development of rhDNase (Dornase Alpha) for the Treatment of Cystic Fibrosis.- Development of the Exubera
    ®
    Insulin Pulmonary Delivery System.- Technosphere®: An Inhalation System for Pulmonary Delivery of Biopharmaceuticals.- ChiSys
    ®
    as a Chitosan-Based Delivery Platform for Nasal Vaccination.- Development of a Cationic Nanoemulsion Platform (Novasorb
    ®
    ) for Ocular Delivery.- Regulatory Aspects and Approval of Biopharmaceuticals for Mucosal Delivery: Quality, Toxicology and Clinical Aspects.